Deerfield Management has added Empire Discovery Institute to its ever-growing roster of partners for its drug discovery engine.
Deerfield Management, the US-based healthcare investment firm, has signed up Empire Discovery Institute (EDI) to its therapeutics commercialisation initiative and expects to invest up to $65m over the next five years. EDI is a non-profit drug discovery and development accelerator focused on bringing academic discoveries into the market. It collaborates with University of Rochester, University…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
